Zoetis (ZTS) Acquisitions (2015 - 2022)
Zoetis (ZTS) posted quarterly Acquisitions of $215.0 million for Q3 2022, down 88.59% quarter-over-quarter from $1.9 billion in Q3 2018.
Zoetis (ZTS) Acquisitions (2015 - 2022) Analysis & Trends
Zoetis (ZTS) has reported Acquisitions for 5 consecutive years, with $215.0 million the latest figure, recorded in Q3 2022.
- In Q3 2022, Acquisitions changed N/A year-over-year to $215.0 million; the TTM figure through Sep 2022 stood at $215.0 million (changed N/A YoY), while the FY2018 annual figure was $1.9 billion, changed N/A from the prior year.
- Acquisitions fell to $215.0 million in Q3 2022 per ZTS's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Acquisitions topped out at $1.9 billion in Q3 2018 and bottomed at $215.0 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 215.00 Mn |
| Sep 30, 2018 | 1.88 Bn |
| Oct 1, 2017 | -3.00 Mn |
| Apr 2, 2017 | 3.00 Mn |
| Oct 2, 2016 | 68.00 Mn |
| Jul 3, 2016 | 8.00 Mn |
| Apr 3, 2016 | 12.00 Mn |
| Dec 31, 2015 | 654.00 Mn |
| Jun 28, 2015 | -1.00 Mn |
| Mar 29, 2015 | 230.00 Mn |